Jasbir Seehra insider trades: Keros Therapeutics (KROS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jasbir reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | KROS | ↓ Sell | 7,015 | $16.17 | $113K | Direct | Feb 20, 2026 (1d) |
| Apr 13, 2020 | KROS | ↑ Buy | 20,000 | $16.00 | $320K | Direct | Apr 13, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KROS insiders
Open-market trades in the last 12 months
About Jasbir Seehra's insider trades
Jasbir Seehra is Chief Executive Officer at Keros Therapeutics (KROS). Since Apr 13, 2020, Jasbir has reported 1 open-market purchase worth $320K and 1 sale worth $113K on SEC Form 4. In the last 12 months: 1 sale ($113K).
Their filings also include grants and awards (12 filings), option exercises (4 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KROS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.